Screening kinase inhibitors identifies MELK as a prime target against influenza virus infections through inhibition of viral mRNA splicing
Influenza epidemics represent a significant threat to global public health, primarily caused by the influenza viruses A and B. Although antiviral drugs targeting the influenza virus, such as zanamivir and oseltamivir, are clinically available, the emergence of virus evolution and drug resistance nec...
Saved in:
| Main Authors: | Xuanye Yang, Xili Feng, Qianyun Liu, Lele An, Zhongren Ma, Xiaoxia Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1600935/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MiR-485-3p/MELK cascade mediates tumor progression in pancreatic cancer
by: Yishan Huang, et al.
Published: (2025-05-01) -
CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis
by: Bo Han, et al.
Published: (2025-07-01) -
Identification of potential therapeutic targets in prostate cancer through a cross‐species approach
by: Sarah Jurmeister, et al.
Published: (2018-02-01) -
Haspin kinase inhibition dampens pseudorabies virus infection in vitro
by: Lei Tan, et al.
Published: (2025-04-01) -
The effect of the PKR inhibitor, 2-aminopurine, on the replication of influenza A virus, and segment 8 mRNA splicing
by: Lorent Dagny, et al.
Published: (2025-04-01)